The bone growth therapies unit was under Orthofix’s spine segment, according to a Feb. 29 news release. As part of realignment bone growth therapies will be managed by Mr. Shallenberger, and spine will be managed under another president.
Mr. Shallenberger was previously vice president of U.S. sales and marketing for bone growth therapies. He joined the company in 2005 as a territory manager and held various leadership positions with the company.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.